NCT04882930

Brief Summary

Brain activation can be studied using the Functional Near InfraRed Spectroscopy (fNIRS). It was shown that CPF activation during walking and during dual task could be different in stroke patients and in healthy subjects. To date, fNIRS reliability is not completely established during walking and during dual task. Therefore, this study will examine the reproducibility of fNIRS parameters during simple walking and during dual task in healthy subjects and in stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable stroke

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 12, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

June 29, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2023

Completed
Last Updated

August 2, 2024

Status Verified

August 1, 2024

Enrollment Period

2.2 years

First QC Date

April 15, 2021

Last Update Submit

August 1, 2024

Conditions

Keywords

fNIRSreproductibilitystrokegait

Outcome Measures

Primary Outcomes (2)

  • Oxyhemoglobin (HbO) variations during simple walking and during dual task

    HbO will be measured by the NIR spectrometry technique continuously at rest and during walking. This technique allows to measure the variations of HbO concentration by measuring the variations of light absorption by the explored tissues.

    Day 0

  • Deoxyhemoglobin (HbR) variations during simple walking and during dual task

    HbR will be measured by the NIR spectrometry technique continuously at rest and during walking. This technique allows to measure the variations of HbR concentration by measuring the variations of light absorption by the explored tissues.

    Day 0

Secondary Outcomes (6)

  • Oxyhemoglobin (HbO) variations of acute stroke patients

    Day 0

  • Deoxyhemoglobin (HbR) variations of acute stroke patients

    Day 0

  • Oxyhemoglobin (HbO) variations of subacute stroke patients

    Day 0

  • Deoxyhemoglobin (HbR) variations of subacute stroke patients

    Day 0

  • Oxyhemoglobin (HbO) variations using different mathematical treatments.

    Day 0

  • +1 more secondary outcomes

Study Arms (1)

Functional Near-Infrared Spectroscopy (fNIRS) acquisitions

EXPERIMENTAL

The hemodynamic response in CPF will be measured using an Octomon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.

Procedure: Functional Near-Infrared Spectroscopy (fNIRS)

Interventions

All participants will undergo Functional Near-Infrared Spectroscopy (fNIRS). The hemodynamic response in CPF will be measured using an Octomon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.

Functional Near-Infrared Spectroscopy (fNIRS) acquisitions

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute stroke group, subacute stroke group, and control group:
  • Age 50 to 80 years
  • Affiliated with a social security plan
  • Able to walk 20 meters unassisted
  • Acute Stroke and Subacute Stroke Group:
  • Stroke onset less than 14 days (for the acute stroke group) or between 14 days and 6 months (for the subacute stroke group)
  • Stroke located in the left or right middle cerebral artery.

You may not qualify if:

  • Acute stroke group, subacute stroke group, and control group:
  • Person under guardianship or curatorship
  • Refusal to sign informed consent
  • Known rheumatologic or cardiologic history
  • Medication that alters the vigilance and may affect walking (high dose psychotropic drugs, antispastic drugs).
  • Acute stroke group and subacute stroke group:
  • History of symptomatic stroke
  • Previous neurological disease limiting gait, aphasia or impaired cognitive function (mild cognitive dementia, Alzheimer's or Parkinson's disease)
  • Ambulatory functional category \< 3
  • Control group: neurological medical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Centre de Réadaptation Fonctionnelle et d'Appareillage Le Coteau

La Chapelle-Saint-Mesmin, France

Location

Chu Limoges

Limoges, France

Location

CHR Orléans

Orléans, 45067, France

Location

Related Publications (4)

  • Hermand E, Tapie B, Dupuy O, Fraser S, Compagnat M, Salle JY, Daviet JC, Perrochon A. Prefrontal Cortex Activation During Dual Task With Increasing Cognitive Load in Subacute Stroke Patients: A Pilot Study. Front Aging Neurosci. 2019 Jul 2;11:160. doi: 10.3389/fnagi.2019.00160. eCollection 2019.

    PMID: 31312136BACKGROUND
  • Hawkins KA, Fox EJ, Daly JJ, Rose DK, Christou EA, McGuirk TE, Otzel DM, Butera KA, Chatterjee SA, Clark DJ. Prefrontal over-activation during walking in people with mobility deficits: Interpretation and functional implications. Hum Mov Sci. 2018 Jun;59:46-55. doi: 10.1016/j.humov.2018.03.010. Epub 2018 Mar 29.

    PMID: 29604488BACKGROUND
  • Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther. 1984 Jan;64(1):35-40. doi: 10.1093/ptj/64.1.35.

    PMID: 6691052BACKGROUND
  • Pelicioni PHS, Tijsma M, Lord SR, Menant J. Prefrontal cortical activation measured by fNIRS during walking: effects of age, disease and secondary task. PeerJ. 2019 May 3;7:e6833. doi: 10.7717/peerj.6833. eCollection 2019.

    PMID: 31110922BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Andreea AIGNATOAIE

    CHR d'Orléans

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Healthy subjects, acute stroke patients, subacute stroke patients
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2021

First Posted

May 12, 2021

Study Start

June 29, 2021

Primary Completion

September 8, 2023

Study Completion

September 8, 2023

Last Updated

August 2, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations